Ilsung Pharmaceutical Co Ltd banner

Intrinsic Value

The intrinsic value of Ilsung Pharmaceutical Co Ltd (003120) under the Base Case is 19 837.16 KRW per share. Compared with the current market price of 21 400 KRW, the stock appears Overvalued by 7% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩19 837.16
Overvaluation 7%
Intrinsic Value
Price ₩21 400

Ilsung Pharmaceutical Co Ltd is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor Ilsung Pharmaceutical Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩15 869.73
Get notified when the price drops into your buy zone
Current Price ₩21 400
Intrinsic Value ₩19 837.16
Margin of Safety 20% ₩15 869.73
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Ilsung Pharmaceutical Co Ltd

Fundamental Analysis

What Ilsung Pharmaceutical Does

Pharmaceuticals Health Care

Ilsung Pharmaceutical Co Ltd makes and sells medicines in South Korea. Its product line includes prescription drugs and over-the-counter medicines, with a focus on finished pharmaceutical products that are manufactured, packaged, and sold under its own brands or through healthcare channels. The company earns money by supplying these medicines to hospitals, clinics, pharmacies, and other distributors that serve patients and medical professionals.

Headquarters
Korea KR
Employees
224
IPO date
Jan 14, 1985
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ilsung Pharmaceutical Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Ilsung Pharmaceutical Co Ltd stock?

The intrinsic value for Ilsung Pharmaceutical Co Ltd (003120) under the Base Case is 19 837.16 KRW.

Is Ilsung Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared with the current market price of 21 400 KRW, the stock appears Overvalued by 7% .

Back to Top